Synthesis and Evaluation of [N-methyl-11C]N-Desmethyl-loperamide as a New and Improved PET Radiotracer for Imaging P-gp Function

[11C]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to [N-methyl-11C]N-desmethyl-loperamide ([11C]dLop; [11C]3) precludes quantification. We considered that [11C]3 might itself be a superior radiotracer for imaging...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 51; no. 19; pp. 6034 - 6043
Main Authors Lazarova, Neva, Zoghbi, Sami S, Hong, Jinsoo, Seneca, Nicholas, Tuan, Ed, Gladding, Robert L, Liow, Jeih-San, Taku, Andrew, Innis, Robert B, Pike, Victor W
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 09.10.2008
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract [11C]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to [N-methyl-11C]N-desmethyl-loperamide ([11C]dLop; [11C]3) precludes quantification. We considered that [11C]3 might itself be a superior radiotracer for imaging brain P-gp function and therefore aimed to prepare [11C]3 and characterize its efficacy. An amide precursor (2) was synthesized and methylated with [11C]iodomethane to give [11C]3. After administration of [11C]3 to wild-type mice, brain radioactivity uptake was very low. In P-gp (mdr-1a(−/−)) knockout mice, brain uptake of radioactivity at 30 min increased about 3.5-fold by PET measures, and over 7-fold by ex vivo measures. In knockout mice, brain radioactivity was predominantly (90%) unchanged radiotracer. In monkey PET experiments, brain radioactivity uptake was also very low but after P-gp blockade increased more than 7-fold. [11C]3 is an effective new radiotracer for imaging brain P-gp function and, in favor of future successful quantification, appears free of extensive brain-penetrant radiometabolites.
AbstractList [ 11 C]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to [ N-methyl - 11 C] N - desmethyl -loperamide ([ 11 C]dLop; [ 11 C] 3 ) precludes quantification. We considered that [ 11 C] 3 might itself be a superior radiotracer for imaging brain P-gp function and therefore aimed to prepare [ 11 C] 3 and characterize its efficacy. An amide precursor ( 2 ) was synthesized and methylated with [ 11 C]iodomethane to give [ 11 C] 3 . After administration of [ 11 C] 3 to wild type mice, brain radioactivity uptake was very low. In P-gp ( mdr-1a (−/−)) knockout mice, brain uptake of radioactivity at 30 min increased about 3.5 fold by PET measures, and over seven-fold by ex vivo measures. In knockout mice, brain radioactivity was predominantly (90%) unchanged radiotracer. In monkey PET experiments, brain radioactivity uptake was also very low, but after P-gp blockade increased more than seven-fold. [ 11 C] 3 is an effective new radiotracer for imaging brain P-gp function and, in favor of future successful quantification, appears free of extensive brain-penetrant radiometabolites.
[(11)C]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to [N-methyl-(11)C] N-desmethyl-loperamide ([(11)C]dLop; [(11)C]3) precludes quantification. We considered that [(11)C]3 might itself be a superior radiotracer for imaging brain P-gp function and therefore aimed to prepare [(11)C]3 and characterize its efficacy. An amide precursor (2) was synthesized and methylated with [(11)C]iodomethane to give [(11)C]3. After administration of [(11)C]3 to wild-type mice, brain radioactivity uptake was very low. In P-gp (mdr-1a(-/-)) knockout mice, brain uptake of radioactivity at 30 min increased about 3.5-fold by PET measures, and over 7-fold by ex vivo measures. In knockout mice, brain radioactivity was predominantly (90%) unchanged radiotracer. In monkey PET experiments, brain radioactivity uptake was also very low but after P-gp blockade increased more than 7-fold. [(11)C]3 is an effective new radiotracer for imaging brain P-gp function and, in favor of future successful quantification, appears free of extensive brain-penetrant radiometabolites.
[C-11]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to [N-methyl-C-11]N-desmethyl-loperamide ([C-11]dLop; [C-11]3) precludes quantification. We considered that [C-11]3 might itself be a superior radiotracer for imaging brain P-gp function and therefore aimed to prepare [C-11]3 and characterize its efficacy. An amide precursor (2) was synthesized and methylated with [C-11]iodomethane to give [C-11]3. After administration of [C-11]3 to wild-type mice, brain radioactivity uptake was very low. In P-gp (mdr-la(-/-)) knockout mice, brain uptake of radioactivity at 30 min increased about 3.5-fold by PET measures, and over 7-fold by ex vivo measures. In knockout mice, brain radioactivity was predominantly (90%) unchanged radiotracer. In monkey PET experiments, brain radioactivity uptake was also very low but after P-gp blockade increased more than 7-fold. [C-11]3 is an effective new radiotracer for imaging brain P-gp function and, in favor of future successful quantification, appears free of extensive brain-penetrant radiometabolites.
[11C]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to [N-methyl-11C]N-desmethyl-loperamide ([11C]dLop; [11C]3) precludes quantification. We considered that [11C]3 might itself be a superior radiotracer for imaging brain P-gp function and therefore aimed to prepare [11C]3 and characterize its efficacy. An amide precursor (2) was synthesized and methylated with [11C]iodomethane to give [11C]3. After administration of [11C]3 to wild-type mice, brain radioactivity uptake was very low. In P-gp (mdr-1a(−/−)) knockout mice, brain uptake of radioactivity at 30 min increased about 3.5-fold by PET measures, and over 7-fold by ex vivo measures. In knockout mice, brain radioactivity was predominantly (90%) unchanged radiotracer. In monkey PET experiments, brain radioactivity uptake was also very low but after P-gp blockade increased more than 7-fold. [11C]3 is an effective new radiotracer for imaging brain P-gp function and, in favor of future successful quantification, appears free of extensive brain-penetrant radiometabolites.
Author Seneca, Nicholas
Tuan, Ed
Taku, Andrew
Liow, Jeih-San
Lazarova, Neva
Pike, Victor W
Hong, Jinsoo
Gladding, Robert L
Zoghbi, Sami S
Innis, Robert B
Author_xml – sequence: 1
  givenname: Neva
  surname: Lazarova
  fullname: Lazarova, Neva
– sequence: 2
  givenname: Sami S
  surname: Zoghbi
  fullname: Zoghbi, Sami S
– sequence: 3
  givenname: Jinsoo
  surname: Hong
  fullname: Hong, Jinsoo
– sequence: 4
  givenname: Nicholas
  surname: Seneca
  fullname: Seneca, Nicholas
– sequence: 5
  givenname: Ed
  surname: Tuan
  fullname: Tuan, Ed
– sequence: 6
  givenname: Robert L
  surname: Gladding
  fullname: Gladding, Robert L
– sequence: 7
  givenname: Jeih-San
  surname: Liow
  fullname: Liow, Jeih-San
– sequence: 8
  givenname: Andrew
  surname: Taku
  fullname: Taku, Andrew
– sequence: 9
  givenname: Robert B
  surname: Innis
  fullname: Innis, Robert B
– sequence: 10
  givenname: Victor W
  surname: Pike
  fullname: Pike, Victor W
  email: pikev@mail.nih.gov
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20746752$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/18783208$$D View this record in MEDLINE/PubMed
BookMark eNqNkk1vEzEQhi1URD_gwB9AvnBAaKk_4l3ngoRCCpWiENEAEghZs15v4nTXjuxNSm78dJwmpIB64OSx5nnfGc3MKTpy3hmEnlLyihJGzxetJERQ0j5AJ1QwkvUk6R2hE0IYy1jO-DE6jXFBCOGU8UfomMpCckbkCfp5tXHd3EQbMbgKD9fQrKCz3mFf42_jrDXdfNNklA6-j7O3Ju7_jV-aAK2tDIakxGNzc6u_bJfBr02FJ8Mp_giV9V0AbQKufUhJmFk3w5NstsQXK6e3dR6jhzU00TzZv2fo08VwOnifjT68uxy8GWUgSN5lNSmMZjWUmuqCVbSkQtYGKsEFL4FxVhGZS9OXsuqD0RUVXFLQOQVOdJ-W_Ay93vkuV2VrKm1c6qxRy2BbCBvlwaq_M87O1cyvFct7ORMiGTz70-Cg_D3LBDzfAxA1NHUAp208cIwUvbwQLHFyx92Y0tdRW-O0OWBpSUz0i5yIbUQHtrtdx8CvXJekL_9fmugXO1oHH2Mw9V3PRG0PRx0OJ7Hn_7B6XzkNwzb3KrKdwsbO_DhYQ7hWecELoaaTKzViXya9r8VnRe_GAzqqhV8Fl9Z9j-8vbo7fEQ
CODEN JMCMAR
CitedBy_id crossref_primary_10_1016_j_jconrel_2018_11_009
crossref_primary_10_1177_0271678X16654493
crossref_primary_10_1016_j_tetlet_2012_12_121
crossref_primary_10_1038_clpt_2009_138
crossref_primary_10_1016_j_jconrel_2021_12_031
crossref_primary_10_3390_pharmaceutics14122650
crossref_primary_10_2217_pgs_10_197
crossref_primary_10_1016_j_bmcl_2013_08_024
crossref_primary_10_1016_j_nucmedbio_2009_03_004
crossref_primary_10_1021_cn3001729
crossref_primary_10_2967_jnumed_112_111732
crossref_primary_10_2967_jnumed_109_070151
crossref_primary_10_2967_jnumed_113_130161
crossref_primary_10_1177_0271678X211045444
crossref_primary_10_1021_mp400396k
crossref_primary_10_1016_j_pharmthera_2018_04_006
crossref_primary_10_1021_acs_molpharmaceut_3c01036
crossref_primary_10_1073_pnas_1014641108
crossref_primary_10_1016_j_drup_2012_02_002
crossref_primary_10_1124_dmd_108_024745
crossref_primary_10_1016_j_nucmedbio_2009_10_006
crossref_primary_10_1016_j_nucmedbio_2015_09_001
crossref_primary_10_1007_s12149_013_0725_5
crossref_primary_10_1007_s11307_016_0965_6
crossref_primary_10_1186_2191_219X_3_3
crossref_primary_10_1177_0271678X231202336
crossref_primary_10_1002_jlcr_2993
crossref_primary_10_2967_jnumed_115_164350
crossref_primary_10_2967_jnumed_124_269322
crossref_primary_10_1002_jps_22822
crossref_primary_10_1016_j_nucmedbio_2012_06_013
crossref_primary_10_1186_2191_219X_1_12
crossref_primary_10_1002_cmdc_201300362
crossref_primary_10_1016_j_ejps_2016_06_005
crossref_primary_10_1038_s41568_018_0005_8
crossref_primary_10_1016_j_bmc_2011_02_039
crossref_primary_10_1124_dmd_109_031161
crossref_primary_10_1002_ejoc_200901321
crossref_primary_10_1016_j_bmcl_2024_129818
crossref_primary_10_1016_j_tips_2009_05_005
crossref_primary_10_1016_j_bmc_2010_06_097
crossref_primary_10_1038_jcbfm_2009_160
crossref_primary_10_2967_jnumed_108_058453
crossref_primary_10_2967_jnumed_114_146894
crossref_primary_10_1002_jlcr_3957
crossref_primary_10_1016_j_bmc_2010_06_057
crossref_primary_10_1021_acschemneuro_1c00382
crossref_primary_10_1016_j_ejps_2023_106404
crossref_primary_10_2174_1568026623666221025111528
crossref_primary_10_1016_j_eplepsyres_2010_12_013
crossref_primary_10_1021_acs_molpharmaceut_5b00168
crossref_primary_10_1021_acsptsci_3c00200
crossref_primary_10_1039_c002361b
crossref_primary_10_1016_j_apsb_2021_08_013
crossref_primary_10_1039_c0dt01275k
crossref_primary_10_4236_aad_2013_21003
crossref_primary_10_1186_1471_2342_11_1
crossref_primary_10_1021_mp200563a
crossref_primary_10_1016_j_ejmech_2016_04_058
crossref_primary_10_1016_j_nucmedbio_2009_12_010
crossref_primary_10_2967_jnumed_116_181354
crossref_primary_10_1016_j_neuroimage_2011_12_037
crossref_primary_10_1016_j_nucmedbio_2013_05_008
crossref_primary_10_3390_molecules171214288
crossref_primary_10_2967_jnumed_108_056226
Cites_doi 10.1016/0014-2999(77)90334-X
10.1007/s11307-005-0951-x
10.1021/jm00265a009
10.2967/jnumed.107.047308
10.1177/38.9.1974900
10.1016/S0969-8043(96)00177-7
10.1109/TNS.2003.817282
10.2967/jnumed.106.038778
10.1038/nrc706
10.1002/syn.20348
10.1172/JCI1269
10.1177/026988119300700202
10.1021/jm0707370
10.1016/j.mibio.2003.09.014
10.1002/bms.1200060606
10.1097/00008571-200210000-00005
10.1162/15353500200504166
10.1172/JCI118699
10.1016/0092-8674(94)90212-7
10.1016/0960-894X(95)00426-T
10.1002/ana.20369
10.1016/S0022-3565(24)34974-2
10.1016/0165-0270(88)90184-7
10.1046/j.1471-4159.2001.00113.x
10.1007/BF01295711
10.1067/mcp.2000.109156
10.1016/S0090-9556(24)02977-5
10.1002/ijc.10792
10.1093/jnen/63.10.1038
10.1172/JCI25247
10.1016/S0169-409X(97)00504-8
10.2174/1381612043384736
ContentType Journal Article
Copyright Copyright © 2008 American Chemical Society
2009 INIST-CNRS
Copyright_xml – notice: Copyright © 2008 American Chemical Society
– notice: 2009 INIST-CNRS
DBID BSCLL
AAYXX
CITATION
17B
1KM
BLEPL
DTL
EGQ
GAYFB
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
5PM
DOI 10.1021/jm800510m
DatabaseName Istex
CrossRef
Web of Knowledge
Index Chemicus
Web of Science Core Collection
Science Citation Index Expanded
Web of Science Primary (SCIE, SSCI & AHCI)
Web of Science - Science Citation Index Expanded - 2008
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
Web of Science
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList
MEDLINE
Web of Science

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 1KM
  name: Index Chemicus
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC
  sourceTypes:
    Enrichment Source
    Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate Synthesis and Evaluation of [11C]N-Desmethyl-loperamide
EISSN 1520-4804
EndPage 6043
ExternalDocumentID PMC2646255
18783208
20746752
000259760500021
10_1021_jm800510m
ark_67375_TPS_L2WP4Z7V_1
c789292902
Genre Journal Article
Research Support, N.I.H., Intramural
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NATIONAL INSTITUTE OF MENTAL HEALTH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)
  grantid: Z01MH002795
– fundername: National Institute of Mental Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)
  grantid: Z01-MH-002795-04
– fundername: NIMH NIH HHS
  grantid: N01 MH032004
– fundername: Intramural NIH HHS
  grantid: Z01 MH002795
– fundername: NIMH NIH HHS
  grantid: Z01-MH-002795-04
– fundername: Intramural NIH HHS
  grantid: Z01 MH002793
GroupedDBID -
.K2
4.4
53G
55A
5GY
5RE
5VS
7~N
AABXI
ABFLS
ABMVS
ABOCM
ABPTK
ABUCX
ACGFS
ACJ
ACS
AEESW
AENEX
AFEFF
AFFNX
ALMA_UNASSIGNED_HOLDINGS
ANTXH
AQSVZ
BAANH
CS3
DU5
EBS
ED
ED~
EJD
F5P
GNL
IH9
IHE
JG
JG~
K2
L7B
LG6
P2P
ROL
TN5
UI2
VF5
VG9
W1F
WH7
X
XFK
YZZ
ZY4
---
-~X
AAHBH
AAYOK
ABJNI
ABQRX
ABTAH
ACGFO
ADHLV
AGXLV
AHGAQ
BSCLL
CUPRZ
GGK
IH2
XSW
YQT
AAYXX
ABBLG
ABLBI
ACRPL
ADNMO
AGQPQ
ANPPW
CITATION
17B
1KM
BLEPL
DTL
GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED
GROUPED_WOS_WEB_OF_SCIENCE
.55
.GJ
.HR
1KJ
1WB
3EH
3O-
6P2
6TJ
9M8
ABHMW
ADXHL
AEYZD
IQODW
MVM
NHB
OHT
RNS
UBC
X7M
ZE2
ZGI
CGR
CUY
CVF
ECM
EIF
NPM
5PM
ID FETCH-LOGICAL-a506t-f07ec2fabc1c72d1b158fead5353ba232d0868e988d9aecd15381ac61a30c91b3
IEDL.DBID ACS
ISICitedReferencesCount 79
ISICitedReferencesURI https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000259760500021
ISSN 0022-2623
IngestDate Thu Aug 21 14:06:15 EDT 2025
Mon Jul 21 05:47:00 EDT 2025
Mon Jul 21 09:12:20 EDT 2025
Wed Aug 06 04:52:48 EDT 2025
Fri Aug 29 16:03:25 EDT 2025
Thu Apr 24 23:14:49 EDT 2025
Tue Jul 01 02:13:16 EDT 2025
Wed Oct 30 09:42:09 EDT 2024
Thu Aug 27 13:42:06 EDT 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 19
Keywords GLYCOPROTEIN FUNCTION
TRANSPORTER
RADIOMETABOLITE
IN-VIVO
LOPERAMIDE
OPIOID RECEPTORS
MULTIDRUG-RESISTANCE
BLOOD-BRAIN-BARRIER
EXPRESSION
MODULATION
Transmembrane protein
Loperamide
Intravenous administration
Radiolabelling
Rodentia
P Glycoprotein
Monkey
Central nervous system
Antidiarrheal agent
Carbon Isotopes
Vertebrata
Mammalia
Mouse
Scintigraphic agent
Animal
Piperidine derivatives
Primates
Carbon 11
Carboxamide
Chemical synthesis
Positron emission tomography
Carrier protein
Language English
License CC BY 4.0
LinkModel DirectLink
LogoURL https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg
MergedId FETCHMERGED-LOGICAL-a506t-f07ec2fabc1c72d1b158fead5353ba232d0868e988d9aecd15381ac61a30c91b3
Notes HPLC chromatograms verifying the purities of compounds 1−3 and PET time−activity data for brain regions in P-gp inhibited monkey given naloxone after radiotracer [11C]3. This material is available free of charge via the Internet at http://pubs.acs.org.
ark:/67375/TPS-L2WP4Z7V-1
istex:A4E18CC67AA463F22B03CB1B8894525F822520AD
NIH RePORTER
OpenAccessLink http://doi.org/10.1021/jm800510m
PMID 18783208
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2646255
webofscience_primary_000259760500021CitationCount
crossref_primary_10_1021_jm800510m
pubmed_primary_18783208
pascalfrancis_primary_20746752
crossref_citationtrail_10_1021_jm800510m
webofscience_primary_000259760500021
istex_primary_ark_67375_TPS_L2WP4Z7V_1
acs_journals_10_1021_jm800510m
ProviderPackageCode JG~
55A
AABXI
GNL
VF5
7~N
ACJ
VG9
W1F
ANTXH
ACS
AEESW
AFEFF
.K2
ABMVS
ABUCX
IH9
BAANH
AQSVZ
ED~
UI2
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2008-10-09
PublicationDateYYYYMMDD 2008-10-09
PublicationDate_xml – month: 10
  year: 2008
  text: 2008-10-09
  day: 09
PublicationDecade 2000
PublicationPlace WASHINGTON
PublicationPlace_xml – name: WASHINGTON
– name: Columbus, OH
– name: United States
PublicationTitle Journal of medicinal chemistry
PublicationTitleAbbrev J MED CHEM
PublicationTitleAlternate J. Med. Chem
PublicationYear 2008
Publisher American Chemical Society
Amer Chemical Soc
Publisher_xml – name: American Chemical Society
– name: Amer Chemical Soc
References Kim R. B. (ref4/cit4) 1998; 101
Kortekaas R. (ref10/cit10) 2005; 57
Jones A. K. P. (ref33/cit33) 1988; 23
Passchier J. (ref19/cit19) 2003; 5
Elsinga P. H. (ref13/cit13) 2004; 10
Talbot P. S. (ref35/cit35) 2005; 46
Liow J. (ref47/cit47) 2003; 44
Elsinga P. H. (ref12/cit12) 2005; 7
Kurdziel K. (ref17/cit17) 2003; 44
Waterhouse R. N. (ref29/cit29) 2003; 5
Yoshida K. (ref26/cit26) 1979; 6
Pike V. W. (ref28/cit28) 1993; 7
Shepard R. L. (ref31/cit31) 2003; 103
ref42/cit42
Shiue C. Y. (ref34/cit34) 1991; 18
Elsinga P. H. (ref15/cit15) 1996; 37
Zoghbi S. S. (ref43/cit43) 1997; 40
Paxinos G. (ref48/cit48) 2001
ref38/cit38
Gottesman M. (ref5/cit5) 2002; 2
Vogelgesang S. (ref8/cit8) 2002; 12
ref50/cit50
Tsuji A. (ref1/cit1) 1997; 25
Langford D. (ref9/cit9) 2004; 63
Takano A. (ref16/cit16) 2006; 47
DelVecchio S. (ref21/cit21) 1997; 24
Larsen P. (ref41/cit41) 1997; 48
Madar I. (ref36/cit36) 2007; 48
Awouters F. (ref22/cit22) 1993; 38
Pfister J. R. (ref37/cit37) 1995; 5
Lam F. C. (ref6/cit6) 2001; 76
Cirrito J. R. (ref7/cit7) 2005; 115
Kalgutkar A. S. (ref25/cit25) 2004; 32
Schnkel A. H. (ref39/cit39) 1994; 77
Stokbroekx R. A. (ref27/cit27) 1973; 16
Dantzig A. H. (ref32/cit32) 1999; 290
Clark J. D. (ref40/cit40) 1996
Wilson A. A. (ref20/cit20) 2005; 48
Johnson C. A. (ref46/cit46) 2002; 4
Zoghbi S. S. (ref24/cit24) 2008; 49
Stahl K. D. (ref30/cit30) 1977; 46
Zoghbi S. S. (ref49/cit49) 2006; 47
Liow J. S. (ref11/cit11) 2007; 96
Levchenko A. (ref14/cit14) 2000; 41
Seidel J. (ref45/cit45) 2003; 50
Briard E. (ref44/cit44) 2008; 51
Bigott H. (ref18/cit18) 2005; 4
Cordon-Cardo C. (ref2/cit2) 1990; 9
Schinkel A. (ref3/cit3) 1996; 97
Sadeque A. J. M. (ref23/cit23) 2000; 68
DelVecchio, S (WOS:A1997WL94900008) 1997; 24
STAHL, KD (WOS:A1977ED77900002) 1977; 46
Bigott, Heather M (MEDLINE:15967124); 4
Liow, JS (WOS:000242789700005) 2007; 61
Wilson, AA (WOS:000267210100139) 2005; 48
Tsuji, A (WOS:A1997XJ12900008) 1997; 25
Zoghbi, SS (WOS:000249695800023) 2006; 47
Liow, J (WOS:000182729600530) 2003; 44
PAXINOS G (WOS:000259760500021.28) 2001
Lam, FC (WOS:000167049800019) 2001; 76
Cirrito, JR (WOS:000233022100038) 2005; 115
Kortekaas, R (WOS:000226633800004) 2005; 57
Takano, A (WOS:000240460600010) 2006; 47
Langford, D (WOS:000224500300004) 2004; 63
Pike, Victor W. (BCI:BCI199345056897) 1993; 7
Schinkel, AH (WOS:A1996UQ23800016) 1996; 97
CLARK JD (WOS:000259760500021.6) 1996
Vogelgesang, S (WOS:000178635900005) 2002; 12
Briard, E (WOS:000252127200003) 2008; 51
Kim, RB (WOS:000071668000002) 1998; 101
Madar, I (WOS:000244115600025) 2007; 48
Dantzig, AH (WOS:000081583900051) 1999; 290
Sadeque, AJM (WOS:000089560000002) 2000; 68
STOKBROEKX, RA (WOS:A1973Q001400009) 1973; 16
SCHINKEL, AH (WOS:A1994NM83200005) 1994; 77
Seidel, J (WOS:000185922200005) 2003; 50
ZOGHBI SS (WOS:000259760500021.49) 1997
JOHNSON CA (WOS:000259760500021.14) 2002; 4
Kurdziel, KA (WOS:000184650900024) 2003; 44
Zoghbi, SS (WOS:000254813600026) 2008; 49
JONES, AKP (WOS:A1988M531900006) 1988; 23
Talbot, PS (WOS:000227481700023) 2005; 46
Kalgutkar, AS (WOS:000223375500010) 2004; 32
CARSON RE (WOS:000259760500021.4) 2003
WEBER D (WOS:000259760500021.44) 1989
Levchenko, A (WOS:000085725300023) 2000; 41
YOSHIDA, K (WOS:A1979HL69800005) 1979; 6
Larsen, P (WOS:A1997WF43900001) 1997; 48
CORDONCARDO, C (WOS:A1990DV50300004) 1990; 38
Shepard, RL (WOS:000179696100019) 2003; 103
Elsinga, PH (WOS:000244957700007) 2005; 7
PFISTER, JR (WOS:A1995TC82800005) 1995; 5
Gottesman, MM (WOS:000180397700014) 2002; 2
Elsinga, PH (WOS:A1996VF79700046) 1996; 37
Elsinga, PH (WOS:000221066400004) 2004; 10
PASSCHIER J (WOS:000259760500021.27) 2003; 5
AWOUTERS, F (WOS:A1993LG50500001) 1993; 38
SHIUE, CY (WOS:A1991FF20500003) 1991; 18
Waterhouse, Rikki N (MEDLINE:14667492); 5
References_xml – volume: 46
  start-page: 199
  year: 1977
  ident: ref30/cit30
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/0014-2999(77)90334-X
– volume: 7
  start-page: 37
  year: 2005
  ident: ref12/cit12
  publication-title: Mol. Imaging Biol.
  doi: 10.1007/s11307-005-0951-x
– volume: 46
  start-page: 484
  year: 2005
  ident: ref35/cit35
  publication-title: J. Nucl. Med.
– volume: 16
  start-page: 782
  year: 1973
  ident: ref27/cit27
  publication-title: J. Med. Chem.
  doi: 10.1021/jm00265a009
– volume: 49
  start-page: 649
  year: 2008
  ident: ref24/cit24
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.107.047308
– ident: ref50/cit50
– volume: 9
  start-page: 1277
  year: 1990
  ident: ref2/cit2
  publication-title: J. Histochem. Cytochem.
  doi: 10.1177/38.9.1974900
– volume: 44
  start-page: 162P
  year: 2003
  ident: ref47/cit47
  publication-title: J. Nucl. Med.
– volume: 40
  start-page: 136
  year: 1997
  ident: ref43/cit43
  publication-title: J. Labelled Compd. Radiopharm.
– volume-title: Guide for the Care and Use of Laboratory Animals
  year: 1996
  ident: ref40/cit40
– volume: 48
  start-page: 153
  year: 1997
  ident: ref41/cit41
  publication-title: Appl. Radiat. Isot.
  doi: 10.1016/S0969-8043(96)00177-7
– volume: 50
  start-page: 1347
  year: 2003
  ident: ref45/cit45
  publication-title: IEEE Trans. Nucl. Sci.
  doi: 10.1109/TNS.2003.817282
– volume: 48
  start-page: 207
  year: 2007
  ident: ref36/cit36
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.106.038778
– volume: 37
  start-page: 1571
  year: 1996
  ident: ref15/cit15
  publication-title: J. Nucl. Med.
– volume-title: The Rat Brain in Stereotaxic Coordinates
  year: 2001
  ident: ref48/cit48
– volume: 2
  start-page: 48
  year: 2002
  ident: ref5/cit5
  publication-title: Nat. Rev. Cancer.
  doi: 10.1038/nrc706
– volume: 96
  start-page: 96
  year: 2007
  ident: ref11/cit11
  publication-title: Synapse
  doi: 10.1002/syn.20348
– volume: 18
  start-page: 281
  year: 1991
  ident: ref34/cit34
  publication-title: Nucl. Med. Biol.
– volume: 48
  start-page: S142
  year: 2005
  ident: ref20/cit20
  publication-title: J. Labelled Compd. Radiopharm.
– volume: 24
  start-page: 0
  year: 1997
  ident: ref21/cit21
  publication-title: Eur. J. Nucl. Med
– volume: 101
  start-page: 289
  year: 1998
  ident: ref4/cit4
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI1269
– volume: 7
  start-page: 139
  year: 1993
  ident: ref28/cit28
  publication-title: J. Psychopharmacol.
  doi: 10.1177/026988119300700202
– volume: 51
  start-page: 17
  year: 2008
  ident: ref44/cit44
  publication-title: J. Med. Chem.
  doi: 10.1021/jm0707370
– volume: 5
  start-page: 376
  year: 2003
  ident: ref29/cit29
  publication-title: Mol. Imaging Biol.
  doi: 10.1016/j.mibio.2003.09.014
– ident: ref42/cit42
– volume: 5
  start-page: 121
  year: 2003
  ident: ref19/cit19
  publication-title: Mol. Imaging Biol.
– volume: 6
  start-page: 253
  year: 1979
  ident: ref26/cit26
  publication-title: Biomed. Mass Spectrom.
  doi: 10.1002/bms.1200060606
– ident: ref38/cit38
– volume: 12
  start-page: 535
  year: 2002
  ident: ref8/cit8
  publication-title: Pharmacogenetics
  doi: 10.1097/00008571-200210000-00005
– volume: 4
  start-page: 30
  year: 2005
  ident: ref18/cit18
  publication-title: Mol. Imaging
  doi: 10.1162/15353500200504166
– volume: 97
  start-page: 2517
  year: 1996
  ident: ref3/cit3
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI118699
– volume: 77
  start-page: 491
  year: 1994
  ident: ref39/cit39
  publication-title: Cell
  doi: 10.1016/0092-8674(94)90212-7
– volume: 47
  start-page: 520
  year: 2006
  ident: ref49/cit49
  publication-title: J. Nucl. Med.
– volume: 5
  start-page: 2473
  year: 1995
  ident: ref37/cit37
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/0960-894X(95)00426-T
– volume: 57
  start-page: 176
  year: 2005
  ident: ref10/cit10
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.20369
– volume: 290
  start-page: 854
  year: 1999
  ident: ref32/cit32
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1016/S0022-3565(24)34974-2
– volume: 23
  start-page: 121
  year: 1988
  ident: ref33/cit33
  publication-title: J. Neurosci. Methods
  doi: 10.1016/0165-0270(88)90184-7
– volume: 4
  start-page: S22
  year: 2002
  ident: ref46/cit46
  publication-title: Mol. Imaging Biol.
– volume: 76
  start-page: 1121
  year: 2001
  ident: ref6/cit6
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.2001.00113.x
– volume: 38
  start-page: 977
  year: 1993
  ident: ref22/cit22
  publication-title: Dig. Dis. Sci.
  doi: 10.1007/BF01295711
– volume: 68
  start-page: 231
  year: 2000
  ident: ref23/cit23
  publication-title: Clin. Pharmacol. Ther.
  doi: 10.1067/mcp.2000.109156
– volume: 44
  start-page: 1330
  year: 2003
  ident: ref17/cit17
  publication-title: J. Nucl. Med.
– volume: 32
  start-page: 943
  year: 2004
  ident: ref25/cit25
  publication-title: Drug Metab. Dispos.
  doi: 10.1016/S0090-9556(24)02977-5
– volume: 103
  start-page: 121
  year: 2003
  ident: ref31/cit31
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.10792
– volume: 63
  start-page: 1038
  year: 2004
  ident: ref9/cit9
  publication-title: J. Neuropath. Exp. Neurol.
  doi: 10.1093/jnen/63.10.1038
– volume: 115
  start-page: 3285
  year: 2005
  ident: ref7/cit7
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI25247
– volume: 25
  start-page: 287
  year: 1997
  ident: ref1/cit1
  publication-title: Adv. Drug Delivery Rev.
  doi: 10.1016/S0169-409X(97)00504-8
– volume: 10
  start-page: 1493
  year: 2004
  ident: ref13/cit13
  publication-title: Curr. Pharm. Des.
  doi: 10.2174/1381612043384736
– volume: 41
  start-page: 493
  year: 2000
  ident: ref14/cit14
  publication-title: J. Nucl. Med.
– volume: 47
  start-page: 1427
  year: 2006
  ident: ref16/cit16
  publication-title: J. Nucl. Med.
– volume: 44
  start-page: 1330
  year: 2003
  ident: WOS:000184650900024
  article-title: Biodistribution, radiation dose estimates, and in vivo Pgp modulation studies of F-18-paclitaxel in nonhuman primates
  publication-title: JOURNAL OF NUCLEAR MEDICINE
– year: 2001
  ident: WOS:000259760500021.28
  publication-title: RAT BRAIN STEREOTAXI
– volume: 46
  start-page: 199
  year: 1977
  ident: WOS:A1977ED77900002
  article-title: RECEPTOR AFFINITY AND PHARMACOLOGICAL POTENCY OF A SERIES OF NARCOTIC ANALGESIC, ANTI-DIARRHEAL AND NEUROLEPTIC DRUGS
  publication-title: EUROPEAN JOURNAL OF PHARMACOLOGY
– volume: 6
  start-page: 253
  year: 1979
  ident: WOS:A1979HL69800005
  article-title: METABOLITES OF LOPERAMIDE IN RATS
  publication-title: BIOMEDICAL MASS SPECTROMETRY
– volume: 41
  start-page: 493
  year: 2000
  ident: WOS:000085725300023
  article-title: Evaluation of C-11-colchicine for PET imaging of multiple drug resistance
  publication-title: JOURNAL OF NUCLEAR MEDICINE
– volume: 47
  start-page: 520
  year: 2006
  ident: WOS:000249695800023
  article-title: PET imaging of the dopamine transporter with F-18-FECNT: A polar radiometabolite confounds brain radioligand measurements
  publication-title: JOURNAL OF NUCLEAR MEDICINE
– volume: 24
  start-page: 150
  year: 1997
  ident: WOS:A1997WL94900008
  article-title: In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients
  publication-title: EUROPEAN JOURNAL OF NUCLEAR MEDICINE
– volume: 48
  start-page: 207
  year: 2007
  ident: WOS:000244115600025
  article-title: Imaging delta- and mu-opioid receptors by PET in lung carcinoma patients
  publication-title: JOURNAL OF NUCLEAR MEDICINE
– volume: 48
  start-page: S142
  year: 2005
  ident: WOS:000267210100139
  article-title: PRODUCTION OF THE P-GLYCOPROTEIN MARKER, [C-11]LOPERAMIDE, IN CLINICALLY USEFUL QUANTITIES
  publication-title: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
– volume: 37
  start-page: 1571
  year: 1996
  ident: WOS:A1996VF79700046
  article-title: Carbon-11-labeled daunorubicin and verapamil for probing P-glycoprotein in tumors with PET
  publication-title: JOURNAL OF NUCLEAR MEDICINE
– volume: 10
  start-page: 1493
  year: 2004
  ident: WOS:000221066400004
  article-title: PET studies on P-glycoprotein function in the blood-brain barrier: How it affects uptake and binding of drugs within the CNS
  publication-title: CURRENT PHARMACEUTICAL DESIGN
– volume: 63
  start-page: 1038
  year: 2004
  ident: WOS:000224500300004
  article-title: Altered P-glycoprotein expression in AIDS patients with HIV encephalitis
  publication-title: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
– volume: 101
  start-page: 289
  year: 1998
  ident: WOS:000071668000002
  article-title: The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
  publication-title: JOURNAL OF CLINICAL INVESTIGATION
– year: 1996
  ident: WOS:000259760500021.6
  publication-title: GUIDE CARE USE LAB A
– volume: 5
  start-page: 2473
  year: 1995
  ident: WOS:A1995TC82800005
  article-title: METHANODIBENZOSUBERYLPIPERAZINES AS POTENT MULTIDRUG-RESISTANCE REVERSAL AGENTS
  publication-title: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
– volume: 48
  start-page: 153
  year: 1997
  ident: WOS:A1997WF43900001
  article-title: Synthesis of [C-11]iodomethane by iodination of [C-11]methane
  publication-title: APPLIED RADIATION AND ISOTOPES
– volume: 32
  start-page: 943
  year: 2004
  ident: WOS:000223375500010
  article-title: Identification of an N-methyl-4-phenylpyridinium-like metabolite of the antidiarrheal agent loperamide in human liver microsomes: Underlying reason(s) for the lack of neurotoxicity despite the bioactivation event
  publication-title: DRUG METABOLISM AND DISPOSITION
– volume: 44
  start-page: 163P
  year: 2003
  ident: WOS:000182729600530
  article-title: A single slice rebinning/2D exact positioning OSEM reconstruction for the NIH ATLAS small animal PET scanner.
  publication-title: JOURNAL OF NUCLEAR MEDICINE
– start-page: 136
  year: 1997
  ident: WOS:000259760500021.49
  publication-title: J LABELLED COMP RADI
– volume: 103
  start-page: 121
  year: 2003
  ident: WOS:000179696100019
  article-title: Modulation of P-glycoprotein but not MRPI- or BCRP-mediated drug resistance by LY335979
  publication-title: INTERNATIONAL JOURNAL OF CANCER
  doi: 10.1002/ijc.10792
– volume: 46
  start-page: 484
  year: 2005
  ident: WOS:000227481700023
  article-title: C-11-GR103545, a radiotracer for imaging kappa-opioid receptors in vivo with PET: Synthesis and evaluation in baboons
  publication-title: JOURNAL OF NUCLEAR MEDICINE
– volume: 38
  start-page: 977
  year: 1993
  ident: WOS:A1993LG50500001
  article-title: LOPERAMIDE - SURVEY OF STUDIES ON MECHANISM OF ITS ANTIDIARRHEAL ACTIVITY
  publication-title: DIGESTIVE DISEASES AND SCIENCES
– volume: 57
  start-page: 176
  year: 2005
  ident: WOS:000226633800004
  article-title: Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo
  publication-title: ANNALS OF NEUROLOGY
  doi: 10.1002/ana.20369
– start-page: 447
  year: 1989
  ident: WOS:000259760500021.44
  publication-title: MIRD RADIONUCLIDE DA
– volume: 290
  start-page: 854
  year: 1999
  ident: WOS:000081583900051
  article-title: Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities
  publication-title: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
– volume: 5
  start-page: 121
  year: 2003
  ident: WOS:000259760500021.27
  publication-title: MOL IMAGING BIOL
– volume: 4
  start-page: 30
  ident: MEDLINE:15967124
  article-title: Imaging multidrug resistance P-glycoprotein transport function using microPET with technetium-94m-sestamibi.
  publication-title: Molecular imaging
– volume: 16
  start-page: 782
  year: 1973
  ident: WOS:A1973Q001400009
  article-title: SYNTHETIC ANTIDIARRHEAL AGENTS - 2,2-DIPHENYL-4-(4'-ARYL-4'-HYDROXYPIPERIDINO)BUTYRAMIDES
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
– volume: 77
  start-page: 491
  year: 1994
  ident: WOS:A1994NM83200005
  article-title: DISRUPTION OF THE MOUSE MDR1A P-GLYCOPROTEIN GENE LEADS TO A DEFICIENCY IN THE BLOOD-BRAIN-BARRIER AND TO INCREASED SENSITIVITY TO DRUGS
  publication-title: CELL
– volume: 50
  start-page: 1347
  year: 2003
  ident: WOS:000185922200005
  article-title: Resolution uniformity and sensitivity of the NIH ATLAS small animal PET scanner: Comparison to simulated LSO scanners without depth-of-interaction capability
  publication-title: IEEE TRANSACTIONS ON NUCLEAR SCIENCE
  doi: 10.1109/TNS.2003.817282
– volume: 115
  start-page: 3285
  year: 2005
  ident: WOS:000233022100038
  article-title: P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model
  publication-title: JOURNAL OF CLINICAL INVESTIGATION
  doi: 10.1172/JCI25247
– volume: 2
  start-page: 48
  year: 2002
  ident: WOS:000180397700014
  article-title: Multidrug resistance in cancer: Role of ATP-dependent transporters
  publication-title: NATURE REVIEWS CANCER
  doi: 10.1038/nrc706
– volume: 4
  start-page: S22
  year: 2002
  ident: WOS:000259760500021.14
  publication-title: MOL IMAGING BIOL
– volume: 7
  start-page: 37
  year: 2005
  ident: WOS:000244957700007
  article-title: Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain
  publication-title: MOLECULAR IMAGING AND BIOLOGY
  doi: 10.1007/s11307-005-0951-x
– volume: 12
  start-page: 535
  year: 2002
  ident: WOS:000178635900005
  article-title: Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans
  publication-title: PHARMACOGENETICS
– volume: 68
  start-page: 231
  year: 2000
  ident: WOS:000089560000002
  article-title: Increased drug delivery to the brain by P-glycoprotein inhibition
  publication-title: CLINICAL PHARMACOLOGY & THERAPEUTICS
  doi: 10.1067/mcp.2000.109156
– volume: 76
  start-page: 1121
  year: 2001
  ident: WOS:000167049800019
  article-title: beta-Amyloid efflux mediated by p-glycoprotein
  publication-title: JOURNAL OF NEUROCHEMISTRY
– volume: 49
  start-page: 649
  year: 2008
  ident: WOS:000254813600026
  article-title: C-11-loperamide and its N-desmethyl radiometabolite are avid substrates for brain permeability-glycoprotein efflux
  publication-title: JOURNAL OF NUCLEAR MEDICINE
  doi: 10.2967/jnumed.107.047308
– volume: 18
  start-page: 281
  year: 1991
  ident: WOS:A1991FF20500003
  article-title: A COMPARISON OF THE BRAIN UPTAKE OF N-(CYCLOPROPYL[C-11]METHYL) NORBUPRENORPHINE ([C-11]BUPRENORPHINE) AND N-(CYCLOPROPYL[C-11]METHYL NORDIPRENORPHINE ([C-11]DIPRENORPHINE) IN BABOON USING PET
  publication-title: NUCLEAR MEDICINE AND BIOLOGY
– volume: 23
  start-page: 121
  year: 1988
  ident: WOS:A1988M531900006
  article-title: REGIONAL CEREBRAL OPIOID RECEPTOR STUDIES WITH [C-11] DIPRENORPHINE IN NORMAL VOLUNTEERS
  publication-title: JOURNAL OF NEUROSCIENCE METHODS
– year: 2003
  ident: WOS:000259760500021.4
  publication-title: IEEE NUCL SCI S MED
– volume: 51
  start-page: 17
  year: 2008
  ident: WOS:000252127200003
  article-title: Synthesis and evaluation in monkey of two sensitive C-11-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/jm0707370
– volume: 25
  start-page: 287
  year: 1997
  ident: WOS:A1997XJ12900008
  article-title: Blood-brain barrier function of P-glycoprotein
  publication-title: ADVANCED DRUG DELIVERY REVIEWS
– volume: 61
  start-page: 96
  year: 2007
  ident: WOS:000242789700005
  article-title: Effect of a P-glycoprotein inhibitor, cyclosporin A, on the disposition in rodent brain and blood of the 5-HT1A receptor radioligand, [C-11](R)-(-)-RWAY
  publication-title: SYNAPSE
  doi: 10.1002/syn.20348
– volume: 97
  start-page: 2517
  year: 1996
  ident: WOS:A1996UQ23800016
  article-title: P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs
  publication-title: JOURNAL OF CLINICAL INVESTIGATION
– volume: 7
  start-page: 139
  year: 1993
  ident: BCI:BCI199345056897
  article-title: Positron-emitting radioligands for studies in vivo: Probes for human psychopharmacology
  publication-title: Journal of Psychopharmacology
– volume: 47
  start-page: 1427
  year: 2006
  ident: WOS:000240460600010
  article-title: Evaluation of in vivo P-glycoprotein function at the blood-brain barrier among MDR1 gene polymorphisms by using C-11-verapamil
  publication-title: JOURNAL OF NUCLEAR MEDICINE
– volume: 38
  start-page: 1277
  year: 1990
  ident: WOS:A1990DV50300004
  article-title: EXPRESSION OF THE MULTIDRUG RESISTANCE GENE-PRODUCT (P-GLYCOPROTEIN) IN HUMAN NORMAL AND TUMOR-TISSUES
  publication-title: JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
– volume: 5
  start-page: 376
  ident: MEDLINE:14667492
  article-title: Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents.
  publication-title: Molecular imaging and biology
SSID ssj0003123
Score 2.2305312
Snippet [11C]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to...
[C-11]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to...
[(11)C]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to [N-methyl-(11)C]...
[ 11 C]Loperamide has been proposed for imaging P-glycoprotein (P-gp) function with positron emission tomography (PET), but its metabolism to [ N-methyl - 11...
Source Web of Science
SourceID pubmedcentral
pubmed
pascalfrancis
webofscience
crossref
istex
acs
SourceType Open Access Repository
Index Database
Enrichment Source
Publisher
StartPage 6034
SubjectTerms Animals
ATP Binding Cassette Transporter, Subfamily B - deficiency
ATP Binding Cassette Transporter, Subfamily B - metabolism
Biological and medical sciences
Brain - diagnostic imaging
Brain - metabolism
Carbon Radioisotopes
Chemistry, Medicinal
Contrast media. Radiopharmaceuticals
Injections, Intravenous
Life Sciences & Biomedicine
Loperamide - analogs & derivatives
Loperamide - chemical synthesis
Loperamide - chemistry
Loperamide - pharmacokinetics
Macaca mulatta
Male
Medical sciences
Mice
Mice, Knockout
Molecular Structure
Pharmacology & Pharmacy
Pharmacology. Drug treatments
Positron-Emission Tomography - methods
Radiopharmaceuticals - chemical synthesis
Radiopharmaceuticals - chemistry
Radiopharmaceuticals - pharmacokinetics
Science & Technology
Stereoisomerism
Time Factors
Title Synthesis and Evaluation of [N-methyl-11C]N-Desmethyl-loperamide as a New and Improved PET Radiotracer for Imaging P-gp Function
URI http://dx.doi.org/10.1021/jm800510m
https://api.istex.fr/ark:/67375/TPS-L2WP4Z7V-1/fulltext.pdf
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000259760500021
https://www.ncbi.nlm.nih.gov/pubmed/18783208
https://pubmed.ncbi.nlm.nih.gov/PMC2646255
Volume 51
WOS 000259760500021
WOSCitedRecordID wos000259760500021
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Jb9NAFB6V9gAXlrKZpRpBFXGoi2e8H5FJVCGoLJJCBULWeBYITZwodiXCiZ_Om_GSBMJys-X3vDx_8xZ75nsIHUpIqUOipO2pOLQ94UR2FISuHWgm6DwKODfLx96cBidn3qtz_3wHPf3DH3xKnn-dRgY50ytojwYweHX-kww7d-sS6raU4BSCeUsftK6qQw8vN0LPnrbiNz0VkpVgDVW3sViLQ9vmSP4Sl0wMGtxAL9uVPPXUk4vjyyo_5t9_J3b82-PdRNebHBS_qEFzC-3IYh9dTdrWb_uol9aE1ssjPFqtzyqPcA-nK6rr5W30Y7gsIIMsxyVmhcD9jjoczxT-CE5aAg4mNiHJp1MbStxmfzKbw1mnYyExA00Mntbo1184pMBpf4TfMjGegVG4XGDIrOGgaaiEU_vzHA8gHOvr3EFng_4oObGbng42852gspUTSk4VyznhIRUkJ36kAM2-67s5g_QO0BJEMo4iAWDhQjtkwnhAmOvwmOTuXbRbzAp5H2Go5CB5VT5TinlQl-aBckWu9BmEVHlsoQN46VkzJsvM_G6nUO60FrfQsxYPGW8Y0XVjjsk20Sed6LymAdkm1DOg6iTY4kLPmwv9bJQOs9f0fep9CN9lBO5sA3WdAjXdX3xqoXs1-lYXi0LwvU5koXADl52ApgnfPFKMvxi6cEh5ocj1LXS4juBOUcdEGK9Q1uotuDfyP2JJYy_NnFA9-JelH6JrtOURjh-h3WpxKR9DMlflB2Yw_wT1REQS
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZgexgvXMYtXDYLTRUPy4hzz-MUteqgqyKawcSEIsexoaxNqyaTKE_8dI6dS9upEntrlXMc5-jzuST2dxA64pBSe0Rw3RaBp9uZ4eu-61m6K5mgU99lTB0fOx-6_Qv746VzWdPkyLMwMIkCRirUR_wVuwD58GvqKwBN76NdSEJMiebTcNR6XYuYVsMMbkJMb1iE1lVlBGLFRgTalcb8LXdE0gKMIqpuFmvhaNtWyVvhSYWi3qOqp5F6CLUD5frkpkxP2J9b_I53e8rH6GGdkeLTCkJP0D2e76O9sGkEt486UUVvvTzG8eq0VnGMOzhaEV8vn6K_o2UO-WQxLjDNM9xticTxTOArcNkcUDHRCQm_D3UoeOv_k9kcRp2OM44paGLwu0q_et_BMxx1Y_yZZuMZ2IbxBYY8Gy6q9ko40n_McQ-Cs7zPM3TR68ZhX687POjUMdxSF4bHmSloygjzzIykxPEFYNuxHCulkOwBdlyfB76fAXRYJt0zocwl1DJYQFLrOdrJZzl_iTDUdZDKCocKQW2oUlNXWFkq5AgZF2mgoQMweFKv0CJRH99NKH4ai2vofQOLhNX86LJNx2Sb6LtWdF6RgmwT6ihstRJ0cS130XlOEkejZGB-jexv3peEwMw2wNcqmKoXjGNq6EUFwtXNfA88seFryNuAZysgScM3r-Tjn4o8HBJgKHkdDR2tA7lVlBESVi8UufIXzI3cRSys7SV5FMpX_7P0Idrrx-eDZHA2_PQaPTAbhuHgDdopFzf8LaR5ZXqg1vc_cbNMcw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZgk2AvXAaMcBkWmioelhHnnscptBowSkQ7mEAocnyBsjatmkyiPPHTOXYubadK7C1RznGco88-58T2dxA6EBBSB0QK05VRYLrcCs3QDxzTV0zQWegzpo-Pfej7J2fuu3PvvE4U1VkY6EQBLRV6EV-N6hmXNcMAef1rEmoQTW6ibbVcpxB9HA_amdchttOwg9vg1xsmoVVV5YVYseaFtpVBf6tdkbQAw8iqosWKS9q0XfKKi9LuqHcXfWw_RO9CuTi6LLMj9ucKx-P1v_QeulNHpvi4gtJ9dEPku-h23BSE20WdpKK5Xhzi4fLUVnGIOzhZEmAvHqC_g0UOcWUxKjDNOe62hOJ4KvE3mLoFoGNsEhJ_75uQ-Nb34-kMWp2MuMAUNDHMv1q_-u8hOE66Q_yJ8tEU7MPEHEO8DQ91mSWcmD9muAdOWr3nITrrdYfxiVlXejCpZ_mlKa1AMFvSjBEW2JxkxAslYNxzPCejEPQBhvxQRGHIAUKMq2maUOYT6lgsIpnzCG3l01w8RhjyOwhppUelpC5kq5kvHZ5J1QIXMosMtA9GT-uRWqR6Ed6GJKixuIFeNdBIWc2Trsp1jDeJvmxFZxU5yCahjsZXK0HnF2o3XeClw2SQntpfEvdr8Dkl0LM1ALYKtq4J49kG2quAuHxZGMCMbIUGCtYg2goo8vD1J_nopyYRh0AYUl_PQAerYG4VlaeEUQzJrrqCvpHriMW1vRSfQvnkf5Z-gW4lb3rp6dv--6dox26IhqNnaKucX4rnEO2V2b4e4v8AAw9O9g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+and+Evaluation+of+%5B+N-+methyl-+11+C%5D+N+-Desmethyl-loperamide+as+a+New+and+Improved+PET+Radiotracer+for+Imaging+P-gp+Function&rft.jtitle=Journal+of+medicinal+chemistry&rft.au=Lazarova%2C+Neva&rft.au=Zoghbi%2C+Sami+S.&rft.au=Hong%2C+Jinsoo&rft.au=Seneca%2C+Nicholas&rft.date=2008-10-09&rft.issn=0022-2623&rft.eissn=1520-4804&rft.volume=51&rft.issue=19&rft.spage=6034&rft.epage=6043&rft_id=info:doi/10.1021%2Fjm800510m&rft.externalDBID=n%2Fa&rft.externalDocID=10_1021_jm800510m
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2623&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2623&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2623&client=summon